Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin

ClinicalTrials.gov ID: NCT00630877

Public ClinicalTrials.gov record NCT00630877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel, Multicenter, Placebo-controlled, Prospective Study to Evaluate the Functionality of the Flushing ASsessment Tool (FAST) in Subjects Administered Niaspan® Plus Acetylsalicylic Acid (ASA), Niaspan® Plus ASA Placebo or Niaspan® Placebo Plus ASA Placebo Daily for Six Weeks

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study was to evaluate the psychometric characteristics (reliability, validity, and responsiveness) of a Flushing ASsessment Tool (FAST) in subjects receiving niacin extended-release (NER) plus aspirin (ASA) daily for 6 weeks. The FAST is a questionnaire that was developed to provide a detailed assessment of flushing symptoms and their impact in patients receiving niacin therapy. The effect of aspirin on flushing symptoms, as measured by the FAST, was also evaluated.

Study identification

NCT ID
NCT00630877
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
276 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
May 31, 2008
Completion
May 31, 2008
Last update posted
Oct 8, 2009

2008

United States locations

U.S. sites
40
U.S. states
18
U.S. cities
38
Facility City State ZIP Site status
Not listed Birmingham Alabama 35209
Not listed Anaheim California 92801
Not listed Walnut Creek California 94598
Not listed Denver Colorado 80212
Not listed Brooksville Florida 34613
Not listed Daytona Beach Florida 32127
Not listed Hollywood Florida 33023
Not listed Jacksonville Florida 32216
Not listed Largo Florida 33770
Not listed Miami Florida 33126
Not listed Pembroke Pines Florida 33026
Not listed Boise Idaho 83704
Not listed Chicago Illinois 60610
Not listed Arkansas City Kansas 67005
Not listed Topeka Kansas 66608
Not listed Wichita Kansas 67203
Not listed Wichita Kansas 67207
Not listed St Louis Missouri 63141
Not listed Las Vegas Nevada 89146
Not listed Durham North Carolina 27704
Not listed High Point North Carolina 27262
Not listed Salisbury North Carolina 28144
Not listed Statesville North Carolina 28677
Not listed Cincinnati Ohio 45242
Not listed Portland Oregon 97239
Not listed Duncansville Pennsylvania 16635
Not listed Harleysville Pennsylvania 19438
Not listed Pittsburgh Pennsylvania 15206
Not listed Greer South Carolina 29651
Not listed Austin Texas 78752
Not listed Carrollton Texas 75006
Not listed Dallas Texas 75251
Not listed San Antonio Texas 78217
Not listed San Antonio Texas 78224
Not listed Magna Utah 84044
Not listed Murray Utah 84107
Not listed Sandy City Utah 84094
Not listed Gig Harbor Washington 98335
Not listed Menomonee Falls Wisconsin 53051
Not listed Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Dyslipidemia trials

Other public records listing Dyslipidemia. Sorted by last update posted; newest first. Not a recommendation.

All Dyslipidemia trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00630877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2009 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00630877 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →